February Newsletter Print

Next Meeting

Join us for a compelling session that highlights the power of clinical reasoning through real-world infectious disease cases presented by regional ID fellows. These presentations will showcase complex diagnostic challenges, management dilemmas, and evidence-based decision-making in action. Designed for clinicians, trainees, and educators alike, this event offers a unique opportunity to learn from the next generation of infectious disease specialists as they navigate high-impact cases with academic rigor and clinical insight.

Presentations

Fifty-five Year Old with Headaches- Dr. Hilal Abdessamad, MD, MS

A 55 year old man with headaches and neurologic symptoms associated with inflammatory CSF findings and radiographic sings of meningitis. Despite clinical and lab improvement with therapy, his course had radiologic progression and new spinal involvement, raising diagnostic and management uncertainty. The case shows the challenges of interpreting clinical, CSF, and imaging data in chronic CNS infections and reviews considerations in escalation of therapy when standard treatment appears insufficient.

Hate to Burst Your Bubble...- Dr. Justin Klucher, MD

A pulmonary mass is noted on imaging for a child presenting with pleuritic chest pain. The lesion is noted to have a cystic appearance and septated daughgter cysts suggestive of Echinococcus disease. Management ultimately yields removal of cysts via surgery preceded by complications of cyst rupture prior to removal.

Primum Non Nocere- An Unusual Case of Lactic Acidosis- Dr. Sandesh Gyawali, MBBS

The presentation is focused on unusual case of lactic acidosis in a critically ill patient. It describes a complex patient with HIV/AIDS and need for high suspicion on medications as the causing agent for lactic acidosis. Following the diagnosis, the presentation focuses on review of lactic acidosis due to the culprit medication and its management. 

Disseminated Nocardiosis in a Kidney Transplant Recipient with History of Recent CMV Infection- Dr. Oscar Efrain Sanchez Sura, MD

Pulmonary nocardiosis is a rare but life-threatening disease caused by Nocardia spp. 
Nocardia spp. is typically considered an opportunistic infection (OI), with 80% of cases occurring in immunocompromised patients. 
CMV has been associated with increased risk of coinfection and subsequent infection with opportunistic infections (OIs), especially fungal infections. 

What lurks within the mind of a restaurant employee?- Dr. Kakumanu Prashanth Reddy, MD

Young immunocompetent immigrant male from Central America presents with new onset facial palsy + solitary intra-cranial lesion. Clinical manifestation of the case under discussion. Diversity in clinical presentation, diagnostic challenges encountered and therapeutic approaches for the given scenario.

Register Now

Back to top

Don't forget to Renew!

Membership renewals are open!

Membership is open to health care professionals primarily working in infectious diseases or related fields. Annual and multi-year membership are available!

Fellows, enjoy free membership throughout your postdoc program!

Membership benefits include: 

  • Free registration for all IDSTL educational meetings
  • Access to a strong local community network
  • Presentation opportunities at local educational meetings
  • Regular updates on local and national news, advocacy resources, and professional opportunities
  • Leadership opportunities that help shape and influence the local ID community
Click the link below to sign up or renew your membership today. 

Back to top

Calendar of Events

Upcoming Meetings and Deadlines:

Challenging ID Case Presentation 2026: February 26th

Highlights from CROI 2026: April 23rd

Back to top

IDSA Information

JID for Clinicians: Looking to the future of infectious disease therapeutics

IDSA’s Journal of Infectious Diseases has launched a monthly roundup of JID papers with direct relevance to clinicians. Click here to learn more about advances in treating Shiga toxin-producing E. coli infections, the effectiveness of high-dose influenza vaccination and other research ready to inform clinical practice. 

Back to top

Advocacy

IDSA and HIVMA town hall: Standing up for health & science together 

Join IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA; IDSA President Ronald G. Nahass, MD, MHCM, FIDSA; HIVMA Chair Anna K. Person, MD, FIDSA; and senior staff Feb. 17 at 7 p.m. ET to discuss public policy actions impacting ID and HIV and opportunities to advocate and support your colleagues and the patients and communities you serve. 

 Register today

IDSA/HIVMA Action Center

Constituent input is critical to the work of Congress. This Action Center allows IDSA and HIVMA members and the general public to influence infectious diseases policymaking in Congress and the Administration. Advocates can use this action center to take action on all current advocacy campaigns and learn more about IDSA/HIVMA's key policy issues. As ID/HIV experts, you have an important role in advancing IDSA/HIVMA's policy priorities and can serve as a needed resource for lawmakers. Through advocacy, you can extend your reach beyond the patients you serve.


If you haven't already, sign up for our Member Advocacy Program (MAP) to become a part of IDSA/HIVMA's advocacy team.  

Back to top